Associated Papers
Molecular Features and Actionable Gene Targets of Testicular Germ Cell Tumors in a Real-World Setting.
Morales-Grimany R et al.
International Journal of Molecular Sciences, 2025
Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells.
Sueangoen N et al.
Cancer Immunology, Immunotherapy : Cii, 2024
38349410 (PubMed )
Supplement: 262_2024_3627_MOESM6_ESM.pdf
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA et al.
Acta Neuropathologica Communications, 2020
33087175 (PubMed )
Supplement: 40478_2020_1040_MOESM1_ESM.xlsx › Sheet1
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.
Lier A et al.
Jco Precision Oncology, 2018
35135162 (PubMed )
Supplement: ds_po.18.00171-2.pdf
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Ross JS et al.
Cancer, 2018
29338072 (PubMed )
Supplement: CNCR-124-1358-s002.xlsx › Colon
Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer.
El-Heliebi A et al.
Histochemistry and Cell Biology, 2017
28321501 (PubMed )
Supplement: 418_2017_1557_MOESM4_ESM.xlsx › Tabelle1
RET mutational spectrum in Hirschsprung disease: evaluation of 601 Chinese patients.
So MT et al.
Plos One, 2011
[Molecular biology, basic research and diagnosis of Hirschsprung's disease].
Martucciello G et al.
Der Pathologe, 2007
Select a paper to view details